T&L Co. Ltd (KQ:340570) — Market Cap & Net Worth
Market Cap & Net Worth: T&L Co. Ltd (340570)
T&L Co. Ltd (KQ:340570) has a market capitalization of $303.32 Million (₩447.59 Billion) as of August 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #14633 globally and #451 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying T&L Co. Ltd's stock price ₩55600.00 by its total outstanding shares 8050147 (8.05 Million). See T&L Co. Ltd capital reinvestment ratio to understand how much of operating cash flow is reinvested back into capital assets.
T&L Co. Ltd Market Cap History: 2020 to 2026
T&L Co. Ltd's market capitalization history from 2020 to 2026. Data shows growth from $112.73 Million to $303.32 Million (14.41% CAGR).
Index Memberships
T&L Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$202.56 Billion | 0.15% | #130 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$202.56 Billion | 0.15% | #130 of 1384 |
Weight: T&L Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
T&L Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how T&L Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
T&L Co. Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.01x
T&L Co. Ltd's market cap is 0.01 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $112.73 Million | $40.63 Billion | $10.04 Billion | 0.00x | 0.01x |
| 2021 | $251.44 Million | $71.90 Billion | $19.58 Billion | 0.00x | 0.01x |
| 2022 | $194.82 Million | $81.58 Billion | $21.12 Billion | 0.00x | 0.01x |
| 2023 | $218.22 Million | $115.46 Billion | $27.44 Billion | 0.00x | 0.01x |
| 2024 | $364.97 Million | $174.89 Billion | $46.41 Billion | 0.00x | 0.01x |
Competitor Companies of 340570 by Market Capitalization
Companies near T&L Co. Ltd in the global market cap rankings as of August 4, 2026.
Key companies related to T&L Co. Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
T&L Co. Ltd Historical Marketcap From 2020 to 2026
Between 2020 and today, T&L Co. Ltd's market cap moved from $112.73 Million to $ 303.32 Million, with a yearly change of 14.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩303.32 Million | +13.35% |
| 2025 | ₩267.59 Million | -26.68% |
| 2024 | ₩364.97 Million | +67.25% |
| 2023 | ₩218.22 Million | +12.01% |
| 2022 | ₩194.82 Million | -22.52% |
| 2021 | ₩251.44 Million | +123.05% |
| 2020 | ₩112.73 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of T&L Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $303.32 Million USD |
| MoneyControl | $303.32 Million USD |
| MarketWatch | $303.32 Million USD |
| marketcap.company | $303.32 Million USD |
| Reuters | $303.32 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more